| Revenue growth | FY26 grew to ₹28,163 Cr vs ₹27,548 Cr in FY25. |
|---|---|
| Margins | EBITDA margin compressed to 21% in FY26 from 25.9% in FY25. |
Growth
FY26 Revenue grew to ₹28,163 Cr; PAT reached ₹3,879 Cr (13.8% margin). Q4FY26 revenue was ₹6,541 Cr.
Outlook
Strong US pipeline with 5 assets filed for FY27; $1Bn+ net cash to fuel growth investments.
Risks
Multiple headwinds mentioned; declining PAT and EBITDA margins year-on-year from FY25 peaks.
Earnings Call filed with BSE, NSE: CIPLA. Summary written with AI assistance from the document.
Cipla Ltd: key numbers
- Share price
- ₹1,399.70
- Market cap
- ₹1,13,076 Cr
- Revenue (annual)
- ₹28,163 Cr
- Net profit (annual)
- ₹3,879 Cr
- P/E (TTM)
- 33.5×Sector 50.4×
- Promoter holding
- 29.21%+0.00% QoQ
- FII holding
- 20.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cipla Ltd
All →Cipla Employee Stock Options
Cipla allotted 12,168 equity shares following the exercise of options under its ESOS and ESAR schemes. This increases the company's total paid-up share capital.
Cipla Management Change
Cipla Ltd announced that Mr. Venkata Sai Mungara has transitioned to a subsidiary role, ceasing to be a Senior Management Personnel effective October 1, 2026.
Cipla Other Announcement
Cipla announced it was assigned an ESG rating of 68 by Niche Ninety Nine Capability and Certifications (OPC) Private Limited, a SEBI-registered rating provider.
Cipla Acquisition
Cipla is notifying shareholders and creditors about a Scheme of Amalgamation with Inzpera Healthsciences, providing them an opportunity to submit representations to the NCLT.
Cipla Earnings Call Transcript: Key Takeaways
Cipla delivered record Q1 FY27 revenue of INR 7,119 Cr with 2% reported growth (4% adjusted). Strategy focuses on U.S. respiratory launches and 'One India' chronic therapies.
Cipla Investor Presentation: Key Takeaways
Cipla delivered record Q1 revenue of INR 7,119 Cr, driven by strong growth in India and the US. EBITDA margins stood at 16.7% with PAT at INR 789 Cr.